The treatment, called VIZZ, is the first designed specifically to treat presbyopia - the natural age-related decline in near ...

FARMINGTON HILLS, Mich., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing ...

The US Food and Drug Administration (FDA) has cleared Grifols' investigational new drug (IND) application to initiate a Phase II trial of GRF312 Ophthalmic Solution, an immunoglobulin (IG) eye drop, ...

Prednisolone eye drops may be used to treat eye inflammation, especially before or after eye surgeries. They’re typically only used for a short period of time. Prednisolone is a potent, synthetic ...

Nexthera Co. Ltd. has submitted an IND application to the FDA seeking to conduct a phase I/IIa trial with NT-101, a noninvasive eye drop treatment for wet age-related macular degeneration (AMD).